Your browser doesn't support javascript.
loading
Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy.
Gale, Jeremy D; Gilbert, Steven; Blumenthal, Samuel; Elliott, Tom; Pergola, Pablo E; Goteti, Kosalaram; Scheele, Wim; Perros-Huguet, Christelle.
Afiliação
  • Gale JD; Inflammation and Immunology Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Gilbert S; Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Blumenthal S; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Elliott T; BC Diabetes, Vancouver, British Columbia, Canada.
  • Pergola PE; Renal Associates PA, San Antonio, Texas, USA.
  • Goteti K; Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Scheele W; Clinical Development and Operations, Pfizer Inc, Cambridge, Massachusetts, USA.
  • Perros-Huguet C; Inflammation and Immunology Research Unit, Pfizer Inc, Cambridge, Massachusetts, USA.
Kidney Int Rep ; 3(6): 1316-1327, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30450458
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2018 Tipo de documento: Article